Process / How I Work

A Clear, Defensible, and Collaborative Approach to Scientific & Regulatory Consulting

Your projects benefit from a structured process designed to reduce uncertainty, strengthen scientific defensibility, and keep regulatory submissions moving forward. Each engagement is tailored to your active ingredient(s), your data package, and your team’s needs.

1. Initial Consultation

A focused 20‑minute discussion to understand your chemistry, study package, and regulatory objectives.

  • Clarify scope and timelines
  • Identify immediate risks or data gaps
  • Determine the right level of support

This session ensures alignment before work begins.

2. Assessment & Strategy

A rapid evaluation of your existing data, study plans, and regulatory context.

  • Review of protocols, reports, and historical data
  • Identification of gaps, inconsistencies, or vulnerabilities
  • Development of a clear, defensible strategy

You receive a roadmap that outlines what to generate, refine, or defend.

3. Study Design & Oversight

Hands‑on support to ensure GLP studies are scientifically sound and regulator‑ready.

  • Protocol design and refinement
  • CRO selection and coordination
  • Interim data review and troubleshooting
  • Development of defensible narratives

This stage strengthens study integrity and reduces downstream challenges.

4. Interpretation & Integration

Synthesis of results into a coherent scientific story.

  • Interpretation of complex or arguable findings
  • Weight‑of‑evidence integration
  • Identification of supplemental analyses or bridging strategies

Your data package becomes clearer, stronger, and easier to defend.

5. Dossier Preparation & Agency Interaction

Support through submission and regulatory review.

  • Dossier section drafting and refinement
  • Responses to deficiency letters
  • Preparation for agency meetings

Your submission is aligned, consistent, and anticipates reviewer questions.

6. Ongoing Advisory & Mentoring

Flexible support for teams needing periodic senior‑level guidance.

  • Regular check‑ins
  • Review of protocols and reports
  • Capability building for Study Directors and regulatory staff

This ensures continuity and strengthens internal expertise.